<DOC>
	<DOC>NCT00562016</DOC>
	<brief_summary>The IMPELLAÂ® 2.5 System will be superior to Intra Aortic Balloon Pump in preventing the composite rate of major adverse events during and after the PCI procedure.</brief_summary>
	<brief_title>Protect II, A Prospective, Multicenter Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Informed consent Subject is indicated for a NON emergent percutaneous treatment of at least on de novo or restenotic lesion in a native coronary vessel or bypass graft. Patient presents with: A compromised Ejection Fraction Intervention on the last patent coronary conduit Intervention on an unprotected left main artery or Patient presenting with triple vessel disease. ST elevation M.I. Pre procedure cardiac arrest within 24 hours. Subject in cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Patient undergoing scheduled PCI</keyword>
</DOC>